4 Marijuana Stocks Stepping Up Their Game

CORAL GABLES, FL / ACCESSWIRE / January 29, 2019 / The marijuana stock market has exploded with excitement over the past few weeks, and we've barely reached the one-month mark for the new year. Over time, public opinion on recreational and medicinal cannabis has turned favorable, resulting in added momentum for companies working to develop high-quality consumer products in the cannabis space. Recent reports have indicated that the global cannabis industry is potentially worth as much as $50 billion which should continue to grow as we move toward the future. CLS Holdings USA Inc (OTC:CLSH), OrganiGram Holdings Inc (OGRMF), CV Sciences Inc (CVSI), and MariMed Inc (MRMD) are 4 pot stocks that are heating up on Tuesday.

CLS Holdings USA Inc (OTC:CLSH) is a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries. The Company's business model is comprised of licensing operations, processing operations, processing facilities, product sales, and brand creation.

CLS Holdings USA Inc (OTC:CLSH) announced earlier his month that it had entered into an option to acquire In Good Health, in accordance with the previously executed letter of intent. Subject to the terms and conditions of the Agreement, both involved companies have agreed upon all of the documents necessary to complete the acquisition. The completion of the acquisition of In Good Health remains subject to a number of conditions as set out in the Agreement, but once it is finalized, CLS will work to integrate in Good Health's extensive dispensary network into their corporate framework.

According to the details of the announcement, In Good Health is one of the 48 licensed dispensaries in the state, and currently services over 18,000 registered patients and delivers to 1,700 homes with key product offerings of flower, concentrates, vapes, edibles, pre-rolls, and tinctures. In collaboration with CLS Holdings USA Inc (OTC:CLSH), the two companies will continue to offer quality products to improve the lives of consumers.

For More Information On CLS Holdings USA Inc., Click Here

OrganiGram Holdings Inc (OGRMF), the parent company of Organigram Inc, today announced that it has signed a multi-year extraction contract with Valens GroWorks Corp, a provider of cannabis products and services focused on proprietary extraction methodologies, distillation, cannabinoid isolation, and purification, as well as associated quality testing.

Per the announcement, Valens will extract cannabis flowers and trim from Organigram's Moncton operation as well as hemp to produce extract concentrate. In turn, the concentrate will be used by Organigram to produce oils and, eventually, derivative edible and vaporizable cannabis products.

Greg Engel, CEO of Organigram, commented, ''A key element of that success is partnerships with companies like Valens who can offer the capacity, quality and expertise to help ensure we deliver on our ongoing commitment to meeting the increasing demand of the global medical and adult recreational cannabis markets.''

For More Information On OrganiGram Holdings, Inc., Click Here

CV Sciences Inc (CVSI) announced earlier this month that Michael Mona, Jr., the Company's Founder and former President and Chief Executive Officer, had retired from his position as an employee with the Company. The Company also announced that it had eliminated the title of President, and Michael Mona III, will continue as the Company's Co-Founder and Chief Operating Officer.

Following the announcement of Mona Jr.'s departure, Joseph Dowling, Chief Executive Officer of CV Sciences, said, ''I can speak for the entire Board of Directors in expressing our gratitude to Mr. Mona Jr. for all of his efforts since the Company's founding in 2012. Mike was the visionary in founding this Company and solidifying our primary competitive advantage in the CBD consumer product marketplace - securing key supply agreements from the most respected growers in Europe, ensuring our products the highest quality offered in the marketplace."

For More Information On CV Sciences, Inc., Click Here

MariMed Inc. (MRMD), one of several multi-state cannabis producers, announced earlier this month that the Company had formed MariMed Hemp, Inc, a wholly-owned subsidiary to be entirely focused on hemp-derived CBD products. MariMed Hemp will have a dedicated executive team, proprietary brand and product lines, and distribution and marketing relationships, all separate from MariMed's core cannabis business.